Vitaspring Biomedical (VSBC) Cash & Equivalents (2017 - 2026)
Vitaspring Biomedical (VSBC) posted Cash & Equivalents of $13,367 for fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with $799.00 a year earlier and up 63.7% from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Jan 31, 2026), Vitaspring Biomedical's Cash & Equivalents came in at $2,084, up 666.2% from FY2025.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -46.0% (FY2021 to FY2026).
- In prior fiscal years, Vitaspring Biomedical's Cash & Equivalents was $272.00 in FY2025, $13.00 in FY2024 (-100.0%), $29,656 in FY2023 (-72.3%) and $107,212 in FY2022 (+136.2%).
- The fiscal Q2 2027 figure stands as the highest quarterly Cash & Equivalents since fiscal Q4 2023.
- On a year-over-year basis, Cash & Equivalents increased in 1 of the last four quarters, with growth averaging 138.5%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q4 2026, with growth of 666.2%; the weakest was fiscal Q4 2024, with a decline of 100.0%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $8,167 (Q1 2027), $2,084 (Q4 2026) and $1,960 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | 13,367.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 13,367.00 |
| Apr 30, 2026 | 8,167.00 |
| Jan 31, 2026 | 2,084.00 |
| Oct 31, 2025 | 1,960.00 |
| Jul 31, 2025 | 799.00 |
| Jan 31, 2025 | 272.00 |
| Oct 31, 2024 | 2,062.00 |
| Jul 31, 2024 | 5,525.00 |
| Apr 30, 2024 | 968.00 |
| Jan 31, 2024 | 13.00 |
| Oct 31, 2023 | 2,636.00 |
| Jul 31, 2023 | 7,181.00 |
| Apr 30, 2023 | 2,993.00 |
| Jan 31, 2023 | 29,656.00 |
| Oct 31, 2022 | 24,050.00 |
| Jul 31, 2022 | 21,590.00 |
| Apr 30, 2022 | 79,151.00 |
| Jan 31, 2022 | 107,212.00 |
| Oct 31, 2021 | 214,057.00 |
| Jul 31, 2021 | 614,063.00 |
API Access
Vitaspring Biomedical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();